Compare CTVA & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTVA | VEEV |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Computer Software: Prepackaged Software |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.7B | 36.9B |
| IPO Year | N/A | 2013 |
| Metric | CTVA | VEEV |
|---|---|---|
| Price | $72.87 | $217.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 25 |
| Target Price | $78.38 | ★ $307.83 |
| AVG Volume (30 Days) | ★ 3.5M | 1.6M |
| Earning Date | 02-03-2026 | 03-04-2026 |
| Dividend Yield | ★ 0.99% | N/A |
| EPS Growth | ★ 139.00 | 26.69 |
| EPS | 2.35 | ★ 5.13 |
| Revenue | ★ $17,469,000,000.00 | $3,080,246,000.00 |
| Revenue This Year | $6.91 | $17.74 |
| Revenue Next Year | $3.56 | $12.28 |
| P/E Ratio | ★ $31.09 | $42.47 |
| Revenue Growth | 5.00 | ★ 15.96 |
| 52 Week Low | $53.40 | $201.54 |
| 52 Week High | $77.41 | $310.50 |
| Indicator | CTVA | VEEV |
|---|---|---|
| Relative Strength Index (RSI) | 69.09 | 40.22 |
| Support Level | $68.42 | $215.27 |
| Resistance Level | $72.30 | $227.37 |
| Average True Range (ATR) | 1.34 | 6.73 |
| MACD | 0.28 | 0.01 |
| Stochastic Oscillator | 90.96 | 7.64 |
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in 2026 and will become a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.